CS Analytical Laboratory, an FDA-regulated contract laboratory dedicated to providing regulatory solutions and qualification testing services specifically for drug product and medical device container systems, has announced two key executive promotions:

• Brandon Zurawlow, currently serving as Chief Scientific Officer, will assume the role of Chief Operations Officer
• Sandra Cincotta, currently Director of Quality, will assume the role of Vice President of Quality.

Both promotions are effective immediately.

“With the tremendous growth that CS Analytical has experienced in all phases of its operations over the past four years, it became imperative that we continue to develop our leadership team,” commented Brian Mulhall, CEO. “Both Brandon and Sandra have been instrumental in guiding our company through this growth and expansion period and these new roles provide them with greater control and oversight as we undertake the next phase of company growth and development.”

About Brandon Zurawlow

With more than 14 years of experience specific to container and package system qualification testing, Zurawlow is a leading expert when it comes to container and package testing requirements holistically and especially as it relates to USP 1207 Container Closure Integrity Testing (CCIT).

From company inception, Zurawlow has been instrumental in developing processes that enable the CS Analytical Team to meet or exceed client expectations when it comes to meeting their regulated container testing requirements.

In his new role as Chief Operations Officer, he will expand his reach into all phases of company operations to ensure that CS Analytical continues to develop systems that meet market requirements and continue a path of growth and expansion.

About Sandra Cincotta

Cincotta, a quality system leader with more than 25 years of experience, was instrumental in the development of the CS Analytical quality system which has proven to increase laboratory efficiencies and save clients both time and money.

Over her many years of experience, she has faced and overcome numerous quality challenges and has always remained ahead of the curve when it came to market dynamics and new and enhanced quality system changes. Her experience with both regulatory body and client audits is impressive. She has hosted numerous FDA Inspections and can boast of never being cited for even a simple observation.

In her new role as Vice President of Quality, she will continue to develop quality system processes and procedures that keep CS Analytical on the cutting edge while concurrently taking a more active role in further company expansion and development.